Cargando…

ET-05 PRECLINICAL STUDY OF AN ANTI-HUMAN TISSUE FACTOR ANTIBODY-DRUG CONJUGATE IN A MALIGNANT GLIOMA XENOGRAFT MODEL

Whereas macromolecules such as antibody hardly extravasate from normal blood vessels compared with low molecular agents, macromolecules leak from tumor vasculature because of the enhanced permeability. As a result, macromolecules selectively accumulate at tumor sites. We apply this phenomenon, known...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takashima, Hiroki, Manabe, Shino, Tsuji, Atsushi, Saga, Tsuneo, Tsumura, Ryo, Anzai, Takahiro, Koga, Yoshikatsu, Yasunaga, Masahiro, Kuroda, Jun-Ichiro, Mukasa, Akitake, Matsumura, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213193/ http://dx.doi.org/10.1093/noajnl/vdz039.039

Ejemplares similares

Evaluation of the antitumor mechanism of antibody‐drug conjugates against tissue factor in stroma‐rich allograft models
por: Tsumura, Ryo, et al.
Publicado: (2019)

Development of Antibody–Drug Conjugates Using DDS and Molecular Imaging
por: Yasunaga, Masahiro, et al.
Publicado: (2017)

Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft model
por: Takashima, Hiroki, et al.
Publicado: (2017)

Antitumor effect of antitissue factor antibody‐MMAE conjugate in human pancreatic tumor xenografts
por: Koga, Yoshikatsu, et al.
Publicado: (2015)

Imaging mass spectrometry for the precise design of antibody-drug conjugates
por: Fujiwara, Yuki, et al.
Publicado: (2016)

Radioimmunotherapy with an (211)At‐labeled anti–tissue factor antibody protected by sodium ascorbate
por: Takashima, Hiroki, et al.
Publicado: (2021)

Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2015)

Discovery of an uncovered region in fibrin clots and its clinical significance
por: Hisada, Yohei, et al.
Publicado: (2013)

Stabilization of an (211)At-Labeled Antibody with Sodium Ascorbate
por: Manabe, Shino, et al.
Publicado: (2021)

Preparation and characterization of anti-tissue factor single-chain variable fragment antibody for cancer diagnosis
por: Sato, Ryuta, et al.
Publicado: (2014)

Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease
por: Yasunaga, Masahiro, et al.
Publicado: (2017)

Tumor Targeting of (211)At-Labeled Antibody under Sodium Ascorbate Protection against Radiolysis
por: Takashima, Hiroki, et al.
Publicado: (2022)

Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin
por: Fuchigami, Hirobumi, et al.
Publicado: (2018)

Chromatographic Analysis of the N-Glycan Profile on Therapeutic Antibodies Using FcγRIIIa Affinity Column Chromatography
por: Hiranyakorn, Methanee, et al.
Publicado: (2023)

Utility of epirubicin‐incorporating micelles tagged with anti‐tissue factor antibody clone with no anticoagulant effect
por: Sugaya, Akinori, et al.
Publicado: (2016)

Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer‐specific molecule
por: Yasunaga, Masahiro, et al.
Publicado: (2019)

Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid Tumors
por: Koga, Yoshikatsu, et al.
Publicado: (2019)

Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines
por: Fukuoka, Shota, et al.
Publicado: (2016)

High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer
por: Shiraishi, Takuya, et al.
Publicado: (2021)

Identification of CD73 as the Antigen of an Antigen-Unknown Monoclonal Antibody Established by Exosome Immunization, and Its Antibody–Drug Conjugate Exerts an Antitumor Effect on Glioblastoma Cell Lines
por: Anzai, Takahiro, et al.
Publicado: (2022)

Report of the use of patient‐derived xenograft models in the development of anticancer drugs in Japan
por: Tsumura, Ryo, et al.
Publicado: (2020)

Evaluation of Fluorescence Intensity and Antitumor Effect Using Real-Time Imaging in Photoimmunotherapy
por: Takashima, Kenji, et al.
Publicado: (2022)

The significance of microscopic mass spectrometry with high resolution in the visualisation of drug distribution
por: Yasunaga, Masahiro, et al.
Publicado: (2013)

ML-17 Clinical usefulness of Tirabrutinib in recurrent PCNSL: single institute experience
por: Matsuura, Jin, et al.
Publicado: (2021)

MLTI-15. A CASE SERIES OF PRE-OPERATIVE GAMMA-KNIFE RADIOSURGERY FOR RESECTABLE BRAIN METASTASES
por: Takezaki, Tatsuya, et al.
Publicado: (2019)

EPEN-02. EVALUATION OF TREATMENT OUTCOMES AND EXPRESSION OF EMT-RELATED TRANSCRIPTION FACTORS AS NOVEL THERAPEUTIC TARGETS IN PEDIATRIC EPENDYMOMA
por: Makino, Keishi, et al.
Publicado: (2020)

Improved Recovery of Exfoliated Colonocytes from Feces Using Newly Developed Immunomagnetic Beads
por: Koga, Yoshikatsu, et al.
Publicado: (2008)

Radioimmunotherapy of pancreatic cancer xenografts in nude mice using (90)Y-labeled anti-α(6)β(4) integrin antibody
por: Aung, Winn, et al.
Publicado: (2016)

Genome Medicine for Brain Tumors: Current Status and Future Perspectives
por: MUKASA, Akitake
Publicado: (2020)

2-Methylthio Conversion of N6-Isopentenyladenosine in Mitochondrial tRNAs by CDK5RAP1 Promotes the Maintenance of Glioma-Initiating Cells
por: Yamamoto, Takahiro, et al.
Publicado: (2019)

Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody
por: Aung, Winn, et al.
Publicado: (2018)

(64)Cu-ATSM internal radiotherapy to treat tumors with bevacizumab-induced vascular decrease and hypoxia in human colon carcinoma xenografts
por: Yoshii, Yukie, et al.
Publicado: (2017)

Combined treatment of pancreatic cancer xenograft with (90)Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor
por: Aung, Winn, et al.
Publicado: (2017)

ML-15 The future direction of treatment development for primary central nervous system lymphoma (PCNSL)
por: Shinojima, Naoki, et al.
Publicado: (2020)

TMEM180 contributes to SW480 human colorectal cancer cell proliferation through intra-cellular metabolic pathways
por: Anzai, Takahiro, et al.
Publicado: (2021)

Protection from contamination by (211)At, an enigmatic but promising alpha-particle-emitting radionuclide
por: Ohnuki, Kazunobu, et al.
Publicado: (2022)

Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts
por: Takahashi, Masamichi, et al.
Publicado: (2019)

Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with (90)Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer
por: Sugyo, Aya, et al.
Publicado: (2018)

Patient-derived xenografts as preclinical neuroblastoma models
por: Braekeveldt, Noémie, et al.
Publicado: (2017)

GCT-36. TREATMENT RESULTS AND RADIATION-INDUCED TUMORS IN CASES OF CENTRAL NERVOUS SYSTEM GERM CELL TUMOR: A LONG-TERM FOLLOW-UP STUDY IN KUMAMOTO PREFECTURE
por: Yamamoto, Takahiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n6vde20mcbqnik14dr2hcndu0f